High triglyceride level is associated with severe coronary artery disease in hypertensive subjects

Scandinavian Cardiovascular Journal

Volumn 42, Issue 2, 2008, Pages 146-152

  Chen, Chun Yen ^a,b   Hwu, Chii Min ^d,e   Lin, Ming Wei ^e   Tsai, Cheng Ho ^a,b,c   Yeh, Hung I ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Alcohol intoxication; Coronary artery disease; ECG; Hypertension; P wave; PR interval; QRS duration; QTc interval; Triglycerides

Indexed keywords

BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 41549155627     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430701840325     Document Type: Article

References (21)

1. Castelli WP, Anderson K. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med. 1986;80(Suppl 2A):23-32.
2. MacMahon SW, Macdonald GJ, Blacket RB. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. Arteriosclerosis. 1985;5:391-6.
3. Reaven GM. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med. 1991;90(Suppl 2A):7S-12S.
4. Onat A, Hergenç G, Sari I, Türkmen S, Can G, Sansoy V. Dyslipidemic hypertension: Distinctive features and cardiovascular risk in a prospective population-based study. Am J Hypertens. 2005;18:409-16.
5. Hwu CM, Kwok CF, Kuo CS, Hsiao LC, Lee YS, Wei MJ, et al. Exacerbation of insulin resistance and postprandial triglyceride response in newly diagnosed hypertensive patients with hypertriglyceridaemia. J Hum Hypertens. 2002;16:487-93.
6. Selby JV, Newman B, Quiroga J, Christian JC, Austin MA, Fabsitz RR. Concordance for dyslipidemic hypertension in male twins. JAMA. 1991;265:2079-84.
7. Freedman DS, Gruchow HW, Anderson AJ, Rimm AA, Barboriak JJ. Relation of triglyceride levels to coronary artery disease: The Milwaukee Cardiovascular Data Registry. Am J Epidemiol. 1988;127:1118-30.
8. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LSC, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975;51(4 Suppl):5-40.
9. Gensini GG. A more meaningful scoring system for determining the severity of coronary artery disease. Am J Cardiol. 1983;51:606.
10. Austin MA. Epidemiology of hypertriglyceridemia and cardiovascular disease. Am J Cardiol. 1999;83:13F-6F.
11. Kannel WB. Risk stratification in hypertension: New insights from the Framingham Study. Am J Hypertens. 2000;13:3S-10S.
12. Catalano M, Aronica A, Carzaniga G, Seregni R, Libretti A. Serum lipids and apolipoproteins in patients with essential hypertension. Atherosclerosis. 1991;87:17-22.
13. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003; 139:802-9.
14. Reaven GM. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab. 2003;88:2399-403.
15. Patsch JR, Miesenböck G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 1992;12:1336-45.
16. Koba S, Hirano T, Murayama S, Kotani T, Tsunoda F, Iso Y. Small dense LDL phenotype is associated with postprandial increases of large VLDL and remnant-like particles in patients with acute myocardial infarction. Atherosclerosis. 2003;170: 131-40.
17. Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 2004;276:1496-504.
18. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996;276: 875-81.
19. Fournier N, Atger V, Cogny A, Vedie B, Girel P, Simon A. Analysis of the relationship between triglyceride and HDL-phospholipid concentrations: Consequences on the efflux capacity of serum in the Fu5AH system. Atherosclerosis. 2001;157:315-23.
20. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al, for the ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomized controlled trail. Lancet 2003; 361:1149-58.
21. Pepine CJ, Kowey PR, Kupfer S, Kolloch RE, Benetos A, Mancia G, et al, for the INVEST investigators. Predictors of adverse outcome among patients with hypertension and coronary artery disease. J Am Coll Cardiol. 2006;47:547-51.